Enhabit Q2 net loss $0.2M; adj. EBITDA $25.2M; guides 2024 revenue $1.05-1.063B

Enhabit, Inc.

2024-Q2 EPS reported $0.00 revenue$523,000,000

Net loss $0.2M (diluted EPS $0.00); adj. EPS $0.07; adj. EBITDA $25.2M, up 5.4% YoY.
Home health revenue $210.2M (-1.7%); total admissions +6.4% driven by non-Medicare +25.2%.
Hospice revenue $50.4M (+3.9%); average daily census +2.7% YoY, up sequentially each month since Jan.
2024 guidance: revenue $1.05-1.063B (vs prior $1.076-1.102B), adj. EBITDA $100-106M, adj. EPS $0.19-$0.37.
Reduced bank debt by $15M in quarter; opened one home health de novo in Florida.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.